Of interest is the IL6/sIL6R inhibitory effect on TNFα-mediated expression of MMP10. MMP10 is linked to the control of the resolution phase of inflammation in models of pulmonary inflammation and experimental colitis, where MMP10 deficiency exacerbates the disease [18, 45, 46]. The gene discussed is IL6; the disease is colitis.